序号 |
标题 |
次数 |
作者 |
发布时间 |
74476 |
DOTA-GGG-H6F H6F肽修饰双功能螯合剂DOTA |
127 |
h |
2024-12-18 |
74477 |
越橘叶黄酮脂质体,L6-Lips,提供荧光脂质体定制服务 |
84 |
axc |
2024-12-18 |
74478 |
Mal-PEG4-Val-Ala-PAB-PNP,一种可降解的ADC连接器 |
105 |
WYQ |
2024-12-18 |
74479 |
Boc-Val-Cit-PAB-OC2H5, ADC试剂 |
168 |
kx |
2024-12-18 |
74480 |
DOTA-GPFAPI-04 FAP配体偶联1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂 |
125 |
h |
2024-12-18 |
74481 |
花生四烯酸脂质体,liposomes,containing,arachidonic,acid,,Lipo-DAPE,脂质体纳米载体定制服务 |
88 |
axc |
2024-12-18 |
74482 |
SG3376, ADC试剂 |
87 |
kx |
2024-12-18 |
74483 |
Boc-Val-Ala-OH(CAS号:70396-18-8) |
83 |
WYQ |
2024-12-18 |
74484 |
Boc-Val-Ala-PAB(CAS号:1884577-99-4) |
121 |
WYQ |
2024-12-18 |
74485 |
鬼臼毒素脂质体(POD-Lps)多功能载药脂质体定制服务 |
110 |
axc |
2024-12-18 |
74486 |
HA-ASP-CH2-Gd-DOTA 透明质酸为载体的靶向肿瘤的大分子T1钆基造影剂 |
95 |
h |
2024-12-18 |
74487 |
DOTA-SC691-Br,DOTA偶联卤素取代物 |
104 |
h |
2024-12-18 |
74488 |
小檗碱共载脂质体(Lip-MB),载药脂质体定制服务 |
124 |
axc |
2024-12-18 |
74489 |
Maleimide-(CH2)5-COONHS cas:55750-63-5 6-(马来酰亚胺基)己酸琥珀酰亚胺酯 |
100 |
zyl |
2024-12-18 |
74490 |
DOTA-cetuximab DOTA-西妥昔单抗 |
109 |
h |
2024-12-18 |
74491 |
DOTA-CAIX-P1-4-10 大环配体DOTA修饰靶向碳酸酐酶IX的多肽探针 |
96 |
h |
2024-12-18 |
74492 |
三七皂苷脂质体,PNS-Lip,靶向脂质体定制服务 |
111 |
axc |
2024-12-18 |
74493 |
HS-C15-COOH 巯基-C15-羧基 |
128 |
zyl |
2024-12-18 |
74494 |
MC-VC-PAB-N3, ADC试剂 |
101 |
kx |
2024-12-18 |
74495 |
DSPE-PEG-四氮杂环配体 DSPE-PEG-tetranitroheterocyclic ligand DSPE-PEG-DOTA |
119 |
h |
2024-12-18 |
74496 |
1639939-40-4,MC-Val-Ala-PAB-PNP,ADC定制 |
117 |
wyh |
2024-12-18 |
74497 |
丝裂霉素C-全氟溴辛烷脂质体,PFOB@Lip-MMC,提供荧光脂质体定制服务 |
96 |
axc |
2024-12-18 |
74498 |
HS-(CH2)5-EG2-Biotin 巯基-五烷烃-二聚乙二醇-生物素 |
86 |
zyl |
2024-12-18 |
74499 |
MA-PEG4-Ala-Ala-PAB-PNP,MA-四聚乙二醇-ALA-ALA-PAB-PNP |
82 |
kx |
2024-12-18 |
74500 |
Ac-Nle-Asp-His-D-Phe-Arg-Trp-Gly-Lys(DOTA)-NH2 |
96 |
h |
2024-12-18 |
74501 |
1020112-73-5,2-氨基-1,3-双(羧乙氧基)丙烷盐酸盐,ADC定制 |
71 |
wyh |
2024-12-18 |
74502 |
DOTA-8-Aoc-BBN(7-14)NH2 |
70 |
h |
2024-12-18 |
74503 |
Fmoc-PEG4-Val-Ala-PAB,一种肽合成中常用的保护基 |
91 |
WYQ |
2024-12-18 |
74504 |
盐酸多柔比星脂质体,DOX-Lip,脂质体纳米载体定制服务 |
102 |
axc |
2024-12-18 |
74505 |
Gd-DOTA偶联甘草次酸(GGD) |
137 |
h |
2024-12-18 |
74506 |
HS-(CH2)3-EG12-OCH2-COOH 巯基-3烷烃-十二聚乙二醇-OCH2-羧基 |
101 |
zyl |
2024-12-18 |
74507 |
cas:2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH,ADC定制 |
107 |
wyh |
2024-12-18 |
74508 |
阿仑膦酸钠(ALN)脂质体,多功能载药脂质体定制服务 |
201 |
axc |
2024-12-18 |
74509 |
KGDS多肽修饰的人铁蛋白负载DOTA KGDS-FRT-DOTA |
100 |
h |
2024-12-18 |
74510 |
Fmoc-Val-Ala-PAB-PNP,CAS号:1394238-92-6 |
94 |
WYQ |
2024-12-18 |
74511 |
钆卟啉(Gd-TP)负载石墨烯量子点修饰环肽RGD |
75 |
h |
2024-12-18 |
74512 |
Fmoc-Phe-Lys(Boc)-PAB, ADC试剂 |
75 |
kx |
2024-12-18 |
74513 |
HS-(CH2)11-EG2-NH3+ Cl- 巯基-十一烷烃-二聚乙二醇-NH3+ Cl- |
92 |
zyl |
2024-12-18 |
74514 |
顺铂脂质复合物脂质体,CDDP-MM,载药脂质体定制服务 |
79 |
axc |
2024-12-18 |
74515 |
MWCNT/PEI-FI-DOTA(Gd)-mPEG5K |
86 |
h |
2024-12-18 |
74516 |
Fmoc-PEG4-Val-Ala-PAB-PNP,一种高效且可控的多肽合成技术 |
101 |
WYQ |
2024-12-18 |
74517 |
寡聚透明质酸修饰的鞣花酸脂质体,EA-HA-L,靶向脂质体定制服务 |
112 |
axc |
2024-12-18 |
74518 |
Boc-PEG4-Val-Ala-PAB,一种可降解的ADC连接体 |
93 |
WYQ |
2024-12-18 |
74519 |
双-甲苯磺酸-(2-羟乙基二硫化物),Bis-Tos-(2-hydroxyethyl disulfide),ADC定制 |
97 |
wyh |
2024-12-18 |
74520 |
Fmoc-Arg(boc)2-PAB-OH, ADC试剂 |
120 |
kx |
2024-12-18 |